Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / FOREIGN
-
Total 13F shares
-
325,901
-
Share change
-
+120,530
-
Total reported value
-
$36,044,631
-
Price per share
-
$110.61
-
Number of holders
-
4
-
Value change
-
+$13,332,422
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of Novartis AG - FOREIGN as of Q1 2025
As of 31 Mar 2025,
Novartis AG - FOREIGN was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
325,901 shares.
The largest 4 holders included
Boston Common Asset Management, LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, and Generali Investments CEE, investicni spolecnost, a.s..
This page lists
4
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.